Baird Financial Group’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.11M Buy
143,292
+2,182
+2% +$97.5K 0.01% 732
2026
Q1
$6.8M Buy
141,110
+7,163
+5% +$334K 0.01% 656
2025
Q4
$6.49M Sell
133,947
-31,736
-19% -$1.57M 0.01% 663
2025
Q3
$7.82M Buy
165,683
+5,951
+4% +$287K 0.01% 605
2025
Q2
$7.72M Sell
159,732
-4,429
-3% -$226K 0.01% 582
2025
Q1
$9.1M Buy
164,161
+21,121
+15% +$1.14M 0.02% 531
2024
Q4
$6.9M Sell
143,040
-1,061
-0.7% -$53.9K 0.01% 590
2024
Q3
$8.3M Buy
144,101
+10,355
+8% +$559K 0.02% 558
2024
Q2
$6.49M Buy
133,746
+9,653
+8% +$466K 0.01% 599
2024
Q1
$6.03M Buy
124,093
+13,852
+13% +$676K 0.01% 618
2023
Q4
$5.48M Sell
110,241
-11,175
-9% -$546K 0.01% 639
2023
Q3
$6.51M Buy
121,416
+28,877
+31% +$1.54M 0.02% 546
2023
Q2
$4.99M Buy
92,539
+1,890
+2% +$102K 0.01% 625
2023
Q1
$4.93M Buy
90,649
+7,538
+9% +$367K 0.01% 597
2022
Q4
$4.03M Sell
83,111
-667
-0.8% -$29.3K 0.01% 638
2022
Q3
$3.19M Sell
83,778
-67,781
-45% -$3.02M 0.01% 682
2022
Q2
$7.58M Buy
151,559
+82,194
+118% +$4.36M 0.02% 493
2022
Q1
$3.56M Sell
69,365
-912
-1% -$47.1K 0.01% 702
2021
Q4
$3.52M Buy
70,277
+5,714
+9% +$283K 0.01% 726
2021
Q3
$3.11M Buy
64,563
+3,812
+6% +$194K 0.01% 763
2021
Q2
$3.2M Buy
60,751
+1,622
+3% +$84.6K 0.01% 742
2021
Q1
$2.92M Sell
59,129
-5,940
-9% -$285K 0.01% 746
2020
Q4
$3.16M Sell
65,069
-886
-1% -$43.7K 0.01% 671
2020
Q3
$3.31M Sell
65,955
-10,245
-13% -$527K 0.01% 606
2020
Q2
$3.89M Sell
76,200
-23,632
-24% -$1.15M 0.01% 538
2020
Q1
$4.37M Buy
99,832
+9,677
+11% +$463K 0.02% 472
2019
Q4
$4.53M Sell
90,155
-143,219
-61% -$6.71M 0.02% 553
2019
Q3
$10.8M Sell
233,374
-12,130
-5% -$523K 0.04% 340
2019
Q2
$10.6M Sell
245,504
-1,473
-0.6% -$62.6K 0.04% 347
2019
Q1
$10.9M Sell
246,977
-7,119
-3% -$305K 0.06% 306
2018
Q4
$11M Buy
254,096
+14,028
+6% +$619K 0.07% 275
2018
Q3
$10.8M Sell
240,068
-4,536
-2% -$194K 0.07% 292
2018
Q2
$9.79M Sell
244,604
-1,154
-0.5% -$45.4K 0.07% 297
2018
Q1
$9.85M Sell
245,758
-36,777
-13% -$1.53M 0.07% 290
2017
Q4
$12.1M Sell
282,535
-5,896
-2% -$272K 0.09% 245
2017
Q3
$14.4M Sell
288,431
-58,023
-17% -$2.81M 0.11% 213
2017
Q2
$16.6M Sell
346,454
-69,630
-17% -$3.33M 0.13% 198
2017
Q1
$18.8M Sell
416,084
-329,243
-44% -$14M 0.15% 171
2016
Q4
$30.1M Sell
745,327
-202,032
-21% -$7.96M 0.26% 118
2016
Q3
$36.2M Buy
947,359
+129,156
+16% +$5.18M 0.32% 89
2016
Q2
$34.3M Buy
818,203
+100,657
+14% +$4.13M 0.31% 88
2016
Q1
$28.8M Sell
717,546
-4,488
-0.6% -$180K 0.28% 108
2015
Q4
$30.8M Sell
722,034
-406,923
-36% -$18.7M 0.31% 92
2015
Q3
$53.6M Buy
1,128,957
+7,281
+0.6% +$371K 0.57% 33
2015
Q2
$55.6M Buy
+1,121,676
New +$56.8M 0.55% 33

Other funds holding SNY

Baird Financial Group's SNY Position: Q2 2026 in Review

Baird Financial Group increased its Sanofi (SNY) stake by 1.5% in Q2 2026, buying an estimated $97.5K and bringing the position to 143,292 shares worth $6.11M. The position accounts for 0.01% of the portfolio, ranked #732.

Baird Financial Group first reported a position in SNY in Q2 2015 and has held it in 45 quarters since. The position peaked at $55.6M in Q2 2015. 716 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Baird Financial Group held 143,292 shares of Sanofi worth $6.11M as of Q2 2026.
  • Baird Financial Group bought 2,182 Sanofi shares in Q2 2026, an estimated $97.5K.
  • Sanofi made up 0.01% of Baird Financial Group's portfolio in Q2 2026, its #732 holding.
  • Baird Financial Group first reported a position in Sanofi in Q2 2015 and has held it in 45 quarters since.
  • Baird Financial Group's Sanofi position peaked at $55.6M in Q2 2015.
  • 716 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Baird Financial Group's 13F filing for Q2 2026, filed 12 Aug 2026.